CR20140302A - VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN - Google Patents

VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Info

Publication number
CR20140302A
CR20140302A CR20140302A CR20140302A CR20140302A CR 20140302 A CR20140302 A CR 20140302A CR 20140302 A CR20140302 A CR 20140302A CR 20140302 A CR20140302 A CR 20140302A CR 20140302 A CR20140302 A CR 20140302A
Authority
CR
Costa Rica
Prior art keywords
release
useful
women
continuous use
concept
Prior art date
Application number
CR20140302A
Other languages
Spanish (es)
Inventor
Shu-Chen Chen
Apablaza Marianela Del Carmen Beltrán
Original Assignee
Andrómaco S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrómaco S A Lab filed Critical Andrómaco S A Lab
Priority to CR20140302A priority Critical patent/CR20140302A/en
Publication of CR20140302A publication Critical patent/CR20140302A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Anillo vaginal de liberación sostenida que comprende meloxicam y un agente modulador de la liberación del principio activo, tal como polivinilpirrolidona K-30, que libera el principio activo por al menos 90 días, útil como anticonceptivo de uso continuoSustained-release vaginal ring comprising meloxicam and an active substance release modulating agent, such as polyvinylpyrrolidone K-30, which releases the active substance for at least 90 days, useful as a contraceptive for continuous use

CR20140302A 2014-06-20 2014-06-20 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN CR20140302A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20140302A CR20140302A (en) 2014-06-20 2014-06-20 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20140302A CR20140302A (en) 2014-06-20 2014-06-20 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Publications (1)

Publication Number Publication Date
CR20140302A true CR20140302A (en) 2014-07-23

Family

ID=51453509

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140302A CR20140302A (en) 2014-06-20 2014-06-20 VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN

Country Status (1)

Country Link
CR (1) CR20140302A (en)

Similar Documents

Publication Publication Date Title
CL2017003404A1 (en) Antibacterial compounds
ECSP18094983A (en) PIRAZOLE DERIVATIVES AS INHIBITORS OF PLASMA CALICREIN
NI201700011A (en) 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES.
CO2017001493A2 (en) Kits comprising tigit inhibitors and anticancer agents
CL2011001811A1 (en) A method of treating a patient who has suffered an acute myocardial infarction that comprises the use of an antifibrotic agent.
IL254813B (en) Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
MX2020003546A (en) Extended release pharmaceutical formulation and methods of treatment.
CL2015003072A1 (en) Long-term colchicine release formulations and methods of use thereof.
ECSP18071568A (en) MICROBIAL DIRECT SUPPLY AGENT FOR THE PREVENTION OF A PATHOLOGY OF SHRIMP
CL2017003437A1 (en) Solid oral formulation containing irinotecan and method of preparation thereof
CO2017001842A2 (en) Article and method to maintain menstrual flow inside the vagina
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
AR095691A1 (en) FORMULATION OF AMORFO L-5-METHYLETHYDROPHOLATE (L-5-MTHF-Ca), PROCEDURE, USE
CO2017012645A2 (en) Antihypertensive agent comprising s-1-propenylcysteine or a salt thereof as active ingredient
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
DOP2016000268A (en) AMIDO-AZOLE COMPOUNDS SUBSTITUTED AS TNKS1 AND/OR TNKS2 INHIBITORS
MX2020004063A (en) Systems and methods to produce b cells genetically modified to express selected antibodies.
SG10201902407PA (en) Injectable microparticles for hyper-localized release of therapeutic agents
AR109409A1 (en) COMPOSITE OF 3-PIRIDILOXIFENILDIHIDROURACILO AND ITS USE
AR109407A1 (en) COMPOSITE OF 1-ACETYL-3-PHENYLIDE AND ITS USE
NI201400066A (en) VAGINAL RING THAT INCLUDES MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
CR20140302A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN
CO7131364A2 (en) Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women
DOP2014000142A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN
ECSP14008154A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS A CONTINUOUS USE CONTRACEPTIVE IN WOMEN